Prescription drug prices: why do some pay more than others do?
The fact that sick elderly people without prescription drug coverage pay far more for drugs than do people with private health insurance has created a call for state and federal governments to take action. Antitrust cases have been launched, state price control legislation has been enacted, and proposals for expansion of Medicare have been offered in response to price and spending levels for prescription drugs. This paper offers an analysis aimed at understanding pricing patterns of brand-name prescription drugs. I focus on the basic economic forces that enable differential pricing of products to exist and show how features of the prescription drug market promote such phenomena. The analysis directs policy attention toward how purchasing practices can be changed to better represent groups that pay the most and are most disadvantaged.
Frank
R G
RG
Harvard University, USA.
D000368:Aged; D016527:Drug Costs / Q000145:classification* / Q000706:statistics & numerical data; D004345:Drug Industry / Q000191:economics*; D019981:Health Care Sector / Q000145:classification*; D006291:Health Policy / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D019458:Insurance Coverage / Q000191:economics; D007356:Insurance, Pharmaceutical Services / Q000191:economics; D008329:Managed Care Programs / Q000191:economics; D011306:Prescription Fees / Q000145:classification* / Q000706:statistics & numerical data; D011907:Rate Setting and Review / Q000379:methods; D014481:United States